Nanolynx Biologics Company
Nanolynx Biologics is a drug discovery company that develops nanobody-based therapeutic candidates for immune-related disorders, cancer, and other diseases. The company applies antibody engineering and biologics research to create targeted treatment candidates. Its research activities focus on developing therapeutic molecules designed to interact with specific disease pathways. The company also advances preclinical drug development programs and collaborates within the life sciences and healthcare ecosystem.
Founded Date:
2025-01-01
Employee Number:
1-10
Headquarters:
Allschwil, Basel-Landschaft, Switzerland, Europe
Industry:
Cell, Gene & Biologics Therapeutics
Super Industry:
Biopharma & Life Science Tools
Investors:
DayOne accelerator
Ipo Status:
private
City:
Allschwil
Region:
Basel-Landschaft
Country:
Switzerland
Founders:
Georg Rüedi, Jean-Philippe Bürckert, Maurice Brozzo
